ICM
CVSA

Invenomic Capital Management’s Covista Inc CVSA Stock Holding History

Invenomic Capital Management’s Portfolio CVSA Stock Details CVSA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-152,539
Closed -$5.56M – 143
2022
Q3 		$5.56M Sell
152,539
-200,360
-57% -$7.65M 0.48% 69
2022
Q2 		$12.7M Sell
352,899
-536,805
-60% -$16.9M 0.9% 35
2022
Q1 		$21.4M Buy
889,704
+591,950
+199% +$15.9M 2.29% 6
2021
Q4 		$8.8M Buy
+297,754
New +$9.81M 1.88% 13
2021
Q3 		– Sell
-35,562
Closed -$1.27M – 123
2021
Q2 		$1.27M Buy
35,562
+14,285
+67% +$536K 0.3% 67
2021
Q1 		$842K Sell
21,277
-67,622
-76% -$2.64M 0.19% 88
2020
Q4 		$3.02M Buy
88,899
+17,486
+24% +$499K 0.77% 19
2020
Q3 		$1.75M Buy
+71,413
New +$2.3M 0.97% 35
2020
Q1 		– Sell
-81,600
Closed -$2.85M – 156
2019
Q4 		$2.85M Buy
+81,600
New +$2.81M 1.15% 35

Other funds holding CVSA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Hotchkis & Wiley Capital Management
Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return
FCM
Frontier Capital Management Boston, Massachusetts $9.73B AUM 55.65% 1-Year Est. Return

Invenomic Capital Management's CVSA Position: Q4 2022 in Review

Invenomic Capital Management sold out of Covista Inc (CVSA) in Q4 2022, closing a stake of 152,539 shares — an estimated $5.56M sold.

Invenomic Capital Management first reported a position in CVSA in Q4 2019 and held it in 9 quarters. The position peaked at $21.4M in Q1 2022. 210 funds tracked by Wall St. Rank hold CVSA as of Q4 2022.

  • Invenomic Capital Management reported no remaining Covista Inc position as of Q4 2022 after selling out during the quarter.
  • Invenomic Capital Management sold 152,539 Covista Inc shares in Q4 2022, an estimated $5.56M.
  • Invenomic Capital Management first reported a position in Covista Inc in Q4 2019 and held it in 9 quarters.
  • Invenomic Capital Management's Covista Inc position peaked at $21.4M in Q1 2022.
  • 210 funds tracked by Wall St. Rank held Covista Inc as of Q4 2022.

Based on Invenomic Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.